Modulation of skin norepinephrine turnover by allergen sensitization: impact on contact hypersensitivity and T helper priming.
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D058672:Adrenergic beta-2 Receptor Antagonists; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000485:Allergens / Q000276:immunology; D000818:Animals; D003877:Dermatitis, Contact / Q000276:immunology* / Q000378:metabolism*; D005260:Female; D015870:Gene Expression / Q000187:drug effects / Q000276:immunology; D007375:Interleukin-1 / Q000235:genetics; D015850:Interleukin-6 / Q000235:genetics; D007801:Langerhans Cells / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D009638:Norepinephrine / Q000378:metabolism*; D010081:Oxazolone / Q000494:pharmacology; D011412:Propanolamines / Q000494:pharmacology; D012867:Skin / Q000276:immunology* / Q000294:innervation*; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology
D000276:Adjuvants, Immunologic; D058672:Adrenergic beta-2 Receptor Antagonists; D000319:Adrenergic beta-Antagonists; D000485:Allergens; D007375:Interleukin-1; D015850:Interleukin-6; D011412:Propanolamines; D010081:Oxazolone; C026777:ICI 118551; D009638:Norepinephrine